Escitalopram for Major Depression in Parkinson’s Disease: An Open-Label, Flexible-Dosage Study

Depression and antidepressant use are common in Parkinson’s disease, but the benefit of selective serotonin reuptake inhibitor (SSRI) treatment in this population has not been established. The authors treated 14 Parkinson’s disease patients with major depression with escitalopram in an open-label st...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Weintraub, Daniel, Taraborelli, Donna, Morales, Knashawn H., Duda, John E., Katz, Ira R., Stern, Matthew B.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2006
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1761053/
https://ncbi.nlm.nih.gov/pubmed/16963587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.neuropsych.18.3.377
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky